Difference between revisions of "Part:BBa K1632013:Design"
Line 14: | Line 14: | ||
All the samples were DH5alpha strain with antibiotic resistance to ampicillin and kanamycin.<br> | All the samples were DH5alpha strain with antibiotic resistance to ampicillin and kanamycin.<br> | ||
− | + | (1). PBAD/''araC''_<i>fimE</i>(wild-type) (pSB6A1) + ''fim'' switch[default ON](wild-type)_rbs_<i>gfp</i> (pSB3K3) <br> | |
− | + | (2). PBAD/''araC''_''fimE''(wild-type) (pSB6A1) + ''fim'' switch[default OFF](wild-type)_rbs_''gfp'' (pSB3K3) <br> | |
− | + | (3). pSB6A1 + ''fim'' switch[default ON](wild-type)_rbs_''gfp'' (pSB3K3) …positive control 1<br> | |
− | + | (4). pSB6A1 + ''fim'' switch[default OFF](wild-type)_rbs_''gfp'' (pSB3K3) …negative control 1<br> | |
− | + | (5). PBAD/''araC''_''fimE''(wild-type) (pSB6A1) + J23119_rbs_''gfp'' (pSB3K3) …positive control 2 <br> | |
− | + | (6). PBAD/''araC''_''fimE''(wild-type) (pSB6A1) + rbs_''gfp'' (pSB3K3) …negative control 2 <br> | |
[[Image:Tokyo_Tech_FimE_assay.png|thumb|center|800px|<b>Fig. 1. </b>Plasmids]]<br> | [[Image:Tokyo_Tech_FimE_assay.png|thumb|center|800px|<b>Fig. 1. </b>Plasmids]]<br> | ||
Line 49: | Line 49: | ||
===Result=== | ===Result=== | ||
[[Image:Tokyo_Tech_FimE_assay_Results.png |thumb|center|700px|<b>Fig. 2. </b>The histograms of the samples measured by flow cytometer]]<br> | [[Image:Tokyo_Tech_FimE_assay_Results.png |thumb|center|700px|<b>Fig. 2. </b>The histograms of the samples measured by flow cytometer]]<br> | ||
+ | [[Image:Tokyo_Tech_FLA_FImE_.png |thumb|center|700px|<b>Fig. 3. </b>The histograms of the samples measured by flow cytometer]]<br> | ||
+ | [[Image:Tokyo_Tech_sequence_FimE.png |thumb|center|700px|<b>Fig. 4. </b>The histograms of the samples measured by flow cytometer]]<br> | ||
+ | |||
===Source=== | ===Source=== | ||
Revision as of 23:18, 18 September 2015
PBAD/araC_rbs_fimE(wild-type)
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 1205
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 1144
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 979
Illegal AgeI site found at 1260 - 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI site found at 961
Design Notes
sequence confirmed
Materials and Methods
Construction
All the samples were DH5alpha strain with antibiotic resistance to ampicillin and kanamycin.
(1). PBAD/araC_fimE(wild-type) (pSB6A1) + fim switch[default ON](wild-type)_rbs_gfp (pSB3K3)
(2). PBAD/araC_fimE(wild-type) (pSB6A1) + fim switch[default OFF](wild-type)_rbs_gfp (pSB3K3)
(3). pSB6A1 + fim switch[default ON](wild-type)_rbs_gfp (pSB3K3) …positive control 1
(4). pSB6A1 + fim switch[default OFF](wild-type)_rbs_gfp (pSB3K3) …negative control 1
(5). PBAD/araC_fimE(wild-type) (pSB6A1) + J23119_rbs_gfp (pSB3K3) …positive control 2
(6). PBAD/araC_fimE(wild-type) (pSB6A1) + rbs_gfp (pSB3K3) …negative control 2
Assay protocol
1. Prepare overnight cultures for each sample in 3 mL of LB medium containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration of mass of glucose is 1.0 %) at 37 ℃ for 12h.
2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp, Kan and glucose (final concentration of mass of glucose is 1.0 %).
3. Incubate the cells at 37 ℃, shaking at 180 rpm until the observed OD590 reaches 0.4 (Fresh Culture).
4. After the incubation, take 1 mL of the samples, and centrifuge at 5000x g, 1 min, 25 ℃
5. Remove the supernatant.
6. Suspend the pellet in 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
7. Remove the supernatant.
8. Suspend the pellet in 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
9. Remove the supernatant.
10. Suspend the pellet in 1mL of LB containing Amp and Kan.
11. Add 30 microL of suspension in the following medium.
① 3 mL of LB containing Amp, Kan and 30 microL of sterile water
② 3 mL of LB containing Amp, Kan and 30 microL of 500 microM arabinose (final concentration of arabinose is 5 microM)
③ 3 mL of LB containing Amp, Kan and 30 microL of 1 mM arabinose (final concentration of arabinose is 10 microM)
④ 3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 20 microM)
※ As for C and D, the suspension were added only in medium ① and ④.
12. Incubate the samples at 37 ℃ for 6 hours, shaking at 180 rpm. (Measure the OD590 of all the samples every hour.)
13. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.
14. Remove the supernatant.
15. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3)
16. Dispense all of each suspension into a disposable tube through a cell strainer.
17. Use flow cytometer to measure the fluorescence of GFP. (We used BD FACSCaliburTM Flow Cytometer of Becton, Dickenson and Company.)
Result
Source
Composite of BBa_I0500, BBa_B0034, BBa_K1632011
References
Timothy S. Ham et al. (2006) A Tightly Regulated Inducible Expression System Utilizing the fim Inversion Recombination Switch. Biotechnol Bioeng 94(1):1-4